Cost of Illness Analysis of Human Immuno- Deficiency Virus/Acquired Immuno-Deficiency Syndrome (HIV/AIDS) in a Developing Economy
dc.contributor.author | Giwa A., Giwa H. B., Jamiu M.O. | |
dc.date.accessioned | 2023-05-17T07:55:04Z | |
dc.date.available | 2023-05-17T07:55:04Z | |
dc.date.issued | 2018-09 | |
dc.description.abstract | Background: Highly Active Antiretroviral Therapy is for lifetime of the patients from time of diagnosis of HIV/AIDS. This translates into a substantial cost in drug therapy to the patients, government and donor agencies. Objective: To conduct cost of illness analysis of HIV/AIDS in a Developing Economy in 2016. Methods: A one-year retrospective review of 2560 prescriptions of 396 HIV/AIDS patients' case notes from January to December, 2016 obtained by systematic random sampling from 4800 case-notes of subjects that participated in this study was conducted. Sampling Interval =10 A data collection form was designed and used to collect data generated from the selected case notes. Cost of Illness was determined by prevalence rate method, using direct costs only. Results: The annual cost of illness for the 396 HIV/AIDS patients on highly active antiretroviral therapy was ?40,674,760 (US$127,108.3) with drug, diagnostic/monitoring tests, transport, care/support and personnel cost components of ?25,479,760; US$79,624.3 (62.64%), ?7,200,000; US$22,500 (17.71%), ?1,440,000; US$4,500(3.54%), ?2,880,000; US$9,000 (7.08%) and ?3,675,000; US$11484 (9.03%) respectively. The annual average cost of illness of HIV/AIDS was ?102,714.04 (US$320.98) Conclusion: The annual average cost of illness of HIV/AIDS represent 97% of annual per capita income. This is enormous. The Annual National cost of illness for HIV/AIDS in Nigeria, a developing economy may be about N590 billion annually. | en_US |
dc.identifier.citation | Giwa A., Giwa H. B., Jamiu M.O. (2018). Cost of Illness Analysis of Human Immuno- Deficiency Virus/Acquired Immuno-Deficiency Syndrome (HIV/AIDS) in a Developing Economy. West African Journal of Pharmacy. 29(2); 44-52 | en_US |
dc.identifier.issn | 2384-6674 | |
dc.identifier.uri | https://uilspace.unilorin.edu.ng/handle/20.500.12484/10277 | |
dc.publisher | West African Journal of Pharmacy. | en_US |
dc.subject | Cost of Illness, Analysis, HIV/AIDS, Developing economy | en_US |
dc.title | Cost of Illness Analysis of Human Immuno- Deficiency Virus/Acquired Immuno-Deficiency Syndrome (HIV/AIDS) in a Developing Economy | en_US |
dc.type | Article | en_US |